Skip to main content
Premium Trial:

Request an Annual Quote

Phenomenex Spins Off New Firm Neoteryx Focused on Sample Collection

Premium

NEW YORK (GenomeWeb) – Phenomenex said this week that it is spinning off a new biological samples company, Neoteryx, focused on providing microsampling products that enable simpler, less invasive, and cost-effective methods of collecting and testing biological samples.

The new firm's main technology is its Volumetric Absorptive Microsampling (VAMS) technology. According to the company, the first product based on this technology – the Mitra Microsample Device – can collect 10 µL of fluid in seconds without volumetric blood hematocrit bias.

The company is aiming the product at areas including pharmaceutical development, personalized medicine, clinical research, and clinical diagnostics.

It will compete with a similar device launched this year by Novilytic Laboratories. That company's device, its Noviplex Cards, similarly serves as an alternative to traditional blood draws, processing finger stick blood samples and take it through sample prep and hematocrit standardization on the card.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.